FDA clearances and approvals, off-label use, scope-of-practice rules, and how to read a 510(k) summary without trusting the marketing wrapper.
Dysport is faster and spreads wider. Xeomin is the only naked toxin without complexing proteins. Both FDA-approved for glabellar lines. Here is how they actually differ.
Exosomes are applied after laser to speed recovery, but no product is FDA-approved and the clinical evidence is early-stage. Here is what patients should actually know.
Paradoxical adipose hyperplasia after CoolSculpting is rarer than manufacturers report. A 2025 meta-analysis found incidence 6.67x higher than stated. Covers PAH signs,…
Hyaluronidase dissolves HA filler but also breaks down your own HA, can trigger allergies, and works best with ultrasound guidance. When to dissolve, when to wait, and…
Emsculpt Neo builds muscle and burns fat via HIFEM + RF. CoolSculpting freezes fat cells permanently. They are not interchangeable. Compares FDA data, PAH risk, cost,…
Asian facial anatomy needs forward projection, not lateral widening. How filler technique differs, where over-Westernization happens, migration risk in thicker skin, and…
No federal standard governs who can inject Botox or filler. State rules vary from physician-only to RN-with-supervision. How to read credentials, spot red flags, and ask…
Kybella dissolves submental fat over 2-6 sessions; chin liposuction removes it in one. Compares mechanism, recovery, side effects, cost, and candidacy based on FDA data…
Morpheus8 can reach subcutaneous fat at deeper settings. The FDA's 2025 RF microneedling alert flagged fat loss, burns, and nerve damage. Covers vulnerable facial zones…
PRP has decades of evidence. Exosomes have zero FDA approvals. PDRN sits between them. Head-to-head on mechanism, evidence, regulation, and realistic expectations for…